Results 121 to 130 of about 3,632 (212)

Plasminogen activation and plasmin activity are not necessary to prevent venous thrombosis/thromboembolism. [PDF]

Blood
Sang Y, Menegatti M, Brody JA, Wiggins KL, Cooley BC, Kapfer KN, Kangro K, de Laat B, Peyvandi F, Flick MJ, Smith NL, Shapiro AD, Wolberg AS.   +12 more
europepmc   +1 more source

Plasmin-Antiplasmin Complex as a New Predictive Marker of Postoperative Venous Thromboembolism in Patients with Gynecologic Malignancy. [PDF]

Clin Appl Thromb Hemost
Ma J, Tang Y, Zhou J, Zhao A, Shi J.
europepmc   +1 more source

Az ST-szakasz-elevációval járó szívizominfarktusos betegek ellátásának változása az elmúlt évtizedekben a gyulai megyei kórházban. A „karosszéktől” a szívkatéteres laboratóriumig = The change in hospital care of patients suffering from acute myocardial infarction with ST elevation during the last decades in the county hospital, Gyula – from „armchair” to the hemodynamic laboratory [PDF]

, 2017
Baranyai, Csaba, Dani, Győző, Jambrik, Zoltán, Katona, András, Márk, László, Nagy, Erzsébet, Sziklai, György, Vendrey, Róbert   +7 more
core   +1 more source

Plasma tissue plasminogen activator-inhibitor complex levels in acute myocardial infarction patients: an observational study. [PDF]

BMC Cardiovasc Disord
Feng YF, Su MY, Xu HX, Zhang SZ, Ma YF, Chen HP.   +5 more
europepmc   +1 more source

Contactless edema via plasmin.

Blood
Strickland S, Norris EH.
europepmc   +1 more source

Mendelian randomization reveals plasminogen as a common therapeutic target for myocardial infarction and atrial fibrillation. [PDF]

J Cardiovasc Thorac Res
Charati H, Hamta A.
europepmc   +1 more source

Recombinant chymase inhibits fibrinolysis induced by endogenous plasmin in clotted human blood. [PDF]

Front Immunol
Vincent L, Lapointe C, McDonald PP, Rammos C, Rassaf T, Köllnberger M, Tinel H, Heitmeier S, D'Orléans-Juste P.   +8 more
europepmc   +1 more source

The time course of alpha 2-plasmin inhibitor and plasmin-alpha 2-plasmin inhibitor complex levels in patients with traumatic brain injury. [PDF]

Acta Neurochir (Wien)
Kanaya T, Nakae R, Sekine T, Fujiki Y, Takayama Y, Igarashi Y, Suzuki G, Naoe Y, Yokota H, Yokobori S.   +9 more
europepmc   +1 more source

Clotting and other plasma factors in septicemia [PDF]

, 1980
Fritz, Hans, Jochum, Marianne, Peeters, Hubert, Schießler, Hans, Witte, J.   +4 more
core  

Rationale and Design of the CREATE Trial: A Multicenter, Randomized Comparison of Continuation or Cessation of Single Antithrombotic Therapy at 1 Year After Transcatheter Aortic Valve Replacement. [PDF]

J Am Heart Assoc
Liu R, Li Y, Zhang L, Lu Z, Fu Z, Modine T, Jilahawi H, Pocock S, Wu Y, Song G.   +9 more
europepmc   +1 more source